StockClub

MCRB

MCRBSeres Therapeutics, Inc.$ --
Seres Therapeutics, Inc.

Seres Therapeutics, Inc.

MCRB

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 03/31/2026FY2026 Q1
Revenue
0M USD
YoY +Infinity%
Operating Income
-21M USD
YoY +23.2%
Net Income
-20M USD
YoY -160.9%
EPS
-2.08$
YoY -155.3%

Revenue

$358,000
FY2024 Q2$0
$0
Q2
FY2024 Q3$0
$0
Q3
FY2024 Q4$0
$0
Q4
FY2025 Q1$0
$0
Q1
FY2025 Q2$0
$0
Q2
FY2025 Q3$351,000
$351,000
Q3
FY2025 Q4$789,000
$789,000
Q4
FY2026 Q1$358,000
$358,000
Q1
Actual
+$358,000 (-)

Net Income

$-19.9M
FY2024 Q2$-73M
$-73M
Q2
FY2024 Q3$15.8M
$15.8M
Q3
FY2024 Q4$136,000
$136,000
Q4
FY2025 Q1$32.7M
$32.7M
Q1
FY2025 Q2$12.8M
$12.8M
Q2
FY2025 Q3$21M
$21M
Q3
FY2025 Q4$5.7M
$5.7M
Q4
FY2026 Q1$-19.9M
$-19.9M
Q1
Actual
$-52.6M (-160.9%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020BEAT
Actual:$33.2M
Est:$22.6M
FY2020BEAT
$33.2M
FY2021MISS
Actual:$144.9M
Est:$149.8M
FY2021MISS
$144.9M
FY2022MISS
Actual:$0
Est:$13.8M
FY2022MISS
$0
FY2023MISS
Actual:$0
Est:$126.8M
FY2023MISS
$0
FY2024MISS
Actual:$0
Est:$31M
FY2024MISS
$0
FY2025BEAT
Actual:$789,000
Est:$266,667
FY2025BEAT
$789,000

Analyst Estimates